Employing Parasite Against Cancer: A Lesson From the Canine Tapeworm Echinococcus Granulocus

Cystic echinococcosis (CE), a devastating zoonotic condition caused by the tapeworm Echinococcus granulosus, remain a significant public health problem worldwide. However, after a negative correlation between solid tumor and CE has been incidentally discovered, accumulating evidence have suggested t...

Full description

Saved in:
Bibliographic Details
Main Authors: Wang Guan (Author), Xiaoqin Zhang (Author), Xiao Wang (Author), Shun Lu (Author), Jun Yin (Author), Jinxin Zhang (Author)
Format: Book
Published: Frontiers Media S.A., 2019-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_2335d58f14a843e2b50b3453783c2e2d
042 |a dc 
100 1 0 |a Wang Guan  |e author 
700 1 0 |a Xiaoqin Zhang  |e author 
700 1 0 |a Xiao Wang  |e author 
700 1 0 |a Shun Lu  |e author 
700 1 0 |a Jun Yin  |e author 
700 1 0 |a Jinxin Zhang  |e author 
245 0 0 |a Employing Parasite Against Cancer: A Lesson From the Canine Tapeworm Echinococcus Granulocus 
260 |b Frontiers Media S.A.,   |c 2019-09-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2019.01137 
520 |a Cystic echinococcosis (CE), a devastating zoonotic condition caused by the tapeworm Echinococcus granulosus, remain a significant public health problem worldwide. However, after a negative correlation between solid tumor and CE has been incidentally discovered, accumulating evidence have suggested that this parasite may induce anticancer effect through activating host immune response and secreting molecules with anticancer potential, which may provide some new understanding for immunotherapy. This article will review the evidence supporting the anticancer effect of E. granulosus and its underlying mechanisms and discuss the possible implications in immunotherapy. 
546 |a EN 
690 |a Echinococcus granulosus 
690 |a cancer 
690 |a immunotherapy 
690 |a immune response 
690 |a adjuvant 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 10 (2019) 
787 0 |n https://www.frontiersin.org/article/10.3389/fphar.2019.01137/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/2335d58f14a843e2b50b3453783c2e2d  |z Connect to this object online.